New SEC Form D filing
Axiom Therapeutics Inc., 2026-08-25
A new SEC Form D private-offering notice from Claymont, DE, a $12,287,219 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Axiom Therapeutics Inc. Verified via SEC Form D
Filed 2026-08-25Filed to raise $12,287,219First money in 2026-08-11Raised so far $12,287,219HQ (as filed) Claymont, DESector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- YunoTrade Inc., 2026-08-26, Newark, DE
- XiltriX North America, LLC, 2026-08-26, $3M, San Diego, CA
- LayerV INC, 2026-08-26, $1M, Dover, DE
- Aptevo Therapeutics Inc., 2026-08-26, $3.5M, Seattle, WA
- Impact Laboratory Services, Inc., 2026-08-25, $1.5M, Wilmington, DE
- MalarVx, Inc., 2026-08-25, $2.5M, Seattle, WA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.